peptide t has been researched along with HIV Coinfection in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Gkogka, I; Glykos, NM | 1 |
| Jin, X; Kou, Z; Liu, H; Shen, W; Shu, J | 1 |
| Leoung, G; Pert, CB; Polianova, MT; Ruff, MR; Ruscetti, FW; Strang, S; Tractenberg, RE | 1 |
| Leoung, GS; Pert, CB; Polianova, M; Ruff, MR; Ruscetti, FW; Yang, QE | 1 |
| Pert, CB; Polianova, MT; Ruff, MR; Ruscetti, FW | 1 |
| Hunt, L; Ji, H; Karwatowska-Prokopczuk, E; Kim, J; Pert, CB; Ruff, M; Zukowska-Grojec, Z | 1 |
| Canet, C; Cigana, F; Da Costa Noble, R; Miquel, JL; Paille, C | 1 |
1 review(s) available for peptide t and HIV Coinfection
| Article | Year |
|---|---|
Update on D-ala-peptide T-amide (DAPTA): a viral entry inhibitor that blocks CCR5 chemokine receptors.
Topics: CCR5 Receptor Antagonists; Clinical Trials, Phase II as Topic; HIV Infections; HIV-1; Humans; Peptide T; Receptors, HIV; Virus Replication | 2003 |
1 trial(s) available for peptide t and HIV Coinfection
| Article | Year |
|---|---|
Antiviral and immunological benefits in HIV patients receiving intranasal peptide T (DAPTA).
Topics: Administration, Intranasal; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Coculture Techniques; DNA, Viral; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Lipopolysaccharide Receptors; Macrophages; Monocytes; Neutrophils; Peptide T; Polymerase Chain Reaction; RNA, Viral; Viral Load; Virus Integration; Virus Replication | 2003 |
6 other study(ies) available for peptide t and HIV Coinfection
| Article | Year |
|---|---|
Folding molecular dynamics simulation of T-peptide, a HIV viral entry inhibitor: Structure, dynamics, and comparison with the experimental data.
Topics: HIV Fusion Inhibitors; HIV Infections; Humans; Molecular Dynamics Simulation; Peptide T; Peptides; Protein Structure, Secondary; Solvents; Virus Internalization | 2022 |
A novel polyepitope vaccine elicited HIV peptide specific CD4+ T cell responses in HLA-A2/DRB1 transgenic mice.
Topics: AIDS Vaccines; Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cytokines; Epitopes, T-Lymphocyte; HIV Infections; HIV-1; HLA-A2 Antigen; Humans; Interferon-gamma; Mice; Mice, Inbred BALB C; Mice, Transgenic; Peptide T; Recombinant Proteins; T-Lymphocytes; Vaccines, DNA | 2017 |
Chemokine receptor-5 (CCR5) is a receptor for the HIV entry inhibitor peptide T (DAPTA).
Topics: CCR5 Receptor Antagonists; Cell Line; HIV Infections; HIV-1; Humans; Peptide T; Receptors, CCR5; Virus Replication | 2005 |
HIV envelope protein gp120 induces neuropeptide Y receptor-mediated proliferation of vascular smooth muscle cells: relevance to AIDS cardiovascular pathogenesis.
Topics: Amino Acid Sequence; Animals; Cardiovascular Diseases; Cell Division; Cells, Cultured; HIV; HIV Envelope Protein gp120; HIV Infections; Humans; Hyperplasia; Mitogens; Molecular Sequence Data; Muscle, Smooth, Vascular; Neuropeptide Y; Peptide T; Rats; Receptors, Neuropeptide Y; Sequence Homology, Amino Acid; Vasoactive Intestinal Peptide | 1998 |
Study of peptide T for HIV infection.
Topics: Female; HIV Infections; Humans; Male; Mental Disorders; Peptide T | 1991 |
[How can we organize the fight against H.I.V.?].
Topics: CD4 Antigens; HIV Infections; Humans; Peptide T; Vaccination; Zidovudine | 1990 |